Canton Hathaway, LLC Rani Therapeutics Holdings, Inc. Transaction History

Canton Hathaway, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 19, 2023	SELL	$5.51 - $10.02 $8,816 - $16,032	-1,600 Reduced 9.88%	14,600 $86,000
Q3 2022 Oct 17, 2022	BUY	$8.23 - $12.4 $62,548 - $94,240	7,600 Added 88.37%	16,200 $155,000
Q2 2022 Jul 20, 2022	BUY	$8.0 - $14.25 $68,800 - $122,550	8,600 New	8,600 $89,000
Q1 2022 Apr 12, 2022	SELL	$12.21 - $23.14 $61,050 - $115,700	-5,000 Closed	0 $0
Q4 2021 Jan 06, 2022	SELL	$16.09 - $35.0 $80,450 - $175,000	-5,000 Reduced 50.0%	5,000 $82,000
Q3 2021 Oct 14, 2021	BUY	$10.7 - $21.43 $107,000 - $214,300	10,000 New	10,000 $178,000

5.77M

2.5K

2.2K

Ticker RANI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,492,000
Market Cap $35.8M
Description
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...

Get notified when there are updates to the investment portfolio of Canton Hathaway, LLC, based on Form 13F filings with the SEC.

Stay updated on Canton Hathaway, LLC with notifications on news.